Picard Medical's Emperor Platform Featured in Artificial Organs

Picard Medical announced the publication of an independent commentary in Artificial Organs, examining its next-generation Emperor platform. The article, titled "A New Chapter in the Quest for a Fully Implantable Artificial Heart," highlights recent preclinical studies of the Emperor platform, which combines the Emperor Drive with the SynCardia Total Artificial Heart. These studies demonstrated stable full circulatory support and physiologic autoregulatory behavior, with no device-related intraoperative failures. The company views these successful acute implant studies as an encouraging preclinical milestone as it works towards human clinical evaluation.